Skip to main content
# Title Research Member Research Year
131 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
Dr. Mayada Fawzy Sedik Farghaly 2019
132 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Dr. Hanaan Ahmed Mohammed Ahmed 2019
133 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Dr. Amen Hamdy Zaki Ali 2019
134 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Dr. Hanaan Ahmed Mohammed Ahmed 2019
135 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Prof. Ashraf Zeidan Abdalla Ahmed 2019
136 The Prognostic Implication of CD49d Expression by Flow Cytometry and Trisomy 12 Detection by Fluorescent in situ Hybridization in Chronic Lymphocytic Leukemia Dr. Mayada Fawzy Sedik Farghaly 2019
137 Circulating hematopoietic stem cells, endothelial
progenitor cells and cancer stem cells in
hepatocellular carcinoma patients: contribution to
diagnosis and prognosis
Dr. Ahmed Refaat Abdel Zaher Mubarak 2019
138 Prognostic Value of Telomere Length in Peripheral Blood Leucocytes in Breast Cancer Patients (South Egypt Cancer Institute Experience) Dr. Abeer Elsayed Ali Ibrahim 2019
139 Signet ring carcinoma of the stomach: impact on prognosis and outcome
Dr. Hanaan Ahmed Mohammed Ahmed 2018
140 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX Dr. Amen Hamdy Zaki Ali 2018